Light BioScience has received an official Notice of Allowance from the United States Patent and Trademark Office for the use of Photomodulation and Photobiomodulation services with its proprietary GentleWaves LED System used for improving the appearance of a wide variety of skin conditions. The patent covers key aspects of the Company's core technology for their exclusive process of using light emitting diodes for modulating the activity of living cells.

"This is an important milestone for Light BioScience as it provides a strong competitive advantage for our LED device and adds to our intellectual property portfolio which currently contains over 17 patents issued, allowed or pending in the United States and internationally," said David H. McDaniel, Light BioScience's director of research and principal scientific officer.

The GentleWaves LED System for reducing the visible signs of aging and treating other aesthetic skin concerns debuted at the recent meeting of the American Academy of Dermatology in San Francisco where it received positive acclaim from physician experts and industry alike. It is the first fully integrated anti-aging system that features an LED device with a scientifically developed line of cosmeceuticals and nutraceuticals to achieve remarkably safe skin rejuvenation at an affordable price.